Axsome Thera
(AXSM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,619 | 33,888 | 38,752 | 44,078 | 48,036 |
| TOTAL | $37,999 | $34,755 | $39,917 | $45,066 | $49,033 |
| Non-Current Assets | |||||
| PPE Net | 101 | 104 | 34 | 25 | 17 |
| Other Non-Current Assets | 113 | 59 | 58 | 58 | 27 |
| TOTAL | $214 | $164 | $91 | $83 | $43 |
| Total Assets | $38,213 | $34,919 | $40,008 | $45,148 | $49,076 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,081 | 3,868 | 3,035 | 1,830 | 1,892 |
| Accrued Expenses | 2,820 | 2,868 | 2,069 | 2,083 | 740 |
| TOTAL | $7,171 | $6,736 | $5,104 | $3,914 | $2,632 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,470 | N/A | N/A | N/A | N/A |
| TOTAL | $9,470 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $16,641 | $6,736 | $5,104 | $3,914 | $2,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,196 | 19,153 | 19,149 | 19,149 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -47,642 | -40,313 | -33,118 | -26,306 | -20,440 |
| TOTAL | $21,572 | $28,183 | $34,904 | $41,235 | $46,444 |
| Total Liabilities And Equity | $38,213 | $34,918 | $40,008 | $45,148 | $49,076 |